BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19635647)

  • 1. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.
    Zhu Y; Hu J; Hu Y; Liu W
    Cancer Treat Rev; 2009 Nov; 35(7):590-6. PubMed ID: 19635647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting DNA repair as a promising approach in cancer therapy.
    Damia G; D'Incalci M
    Eur J Cancer; 2007 Aug; 43(12):1791-801. PubMed ID: 17588740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair pathways and their implication in cancer treatment.
    Pallis AG; Karamouzis MV
    Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
    Frosina G
    Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting homologous recombination repair defects in cancer.
    Evers B; Helleday T; Jonkers J
    Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
    Motegi A; Murakawa Y; Takeda S
    Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous recombination in cancer development, treatment and development of drug resistance.
    Helleday T
    Carcinogenesis; 2010 Jun; 31(6):955-60. PubMed ID: 20351092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
    Farrell NP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic deregulation of DNA repair and its potential for therapy.
    Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
    Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer.
    Allinson SL
    Future Oncol; 2010 Jun; 6(6):1031-42. PubMed ID: 20528239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DNA repair mechanisms in cancer.
    Furgason JM; Bahassi el M
    Pharmacol Ther; 2013 Mar; 137(3):298-308. PubMed ID: 23107892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage response and development of targeted cancer treatments.
    Gasser S
    Ann Med; 2007; 39(6):457-64. PubMed ID: 17852036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparity between DNA base excision repair in yeast and mammals: translational implications.
    Kelley MR; Kow YW; Wilson DM
    Cancer Res; 2003 Feb; 63(3):549-54. PubMed ID: 12566294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the DNA damage response for cancer therapy.
    Powell SN; Bindra RS
    DNA Repair (Amst); 2009 Sep; 8(9):1153-65. PubMed ID: 19501553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy.
    Aziz K; Nowsheen S; Pantelias G; Iliakis G; Gorgoulis VG; Georgakilas AG
    Pharmacol Ther; 2012 Mar; 133(3):334-50. PubMed ID: 22197993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy resistance abrogation in metastatic melanoma.
    Tawbi HA; Buch SC
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):259-66. PubMed ID: 20505649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors and drug resistance.
    Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
    Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S; Zabludoff S
    Clin Cancer Res; 2008 Jul; 14(13):4032-7. PubMed ID: 18593978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SMARCAL1 as a novel strategy for cancer therapy.
    Zhang L; Fan S; Liu H; Huang C
    Biochem Biophys Res Commun; 2012 Oct; 427(2):232-5. PubMed ID: 22995303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.